Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50090-5985

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-5985). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure Less Than 140 Mmhg At Week 8 (Image 01)

This is a chart that shows blood pressure measurements. The goal blood pressure is less than 140 mmHg. There are two medication doses listed, 100 and 200 mg. A medication called Hydrochlorothiazide is also listed with a dose of 25 mg. There is a baseline SBP measurement in mmHg.*

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure Less Than 90 Mmhg At Week 8 (Image 02)

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure Less Than 130 Mmhg At Week 8 (Image 03)

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure Less Than 80 Mmhg At Week 8 (Image 04)

This is a medical document that lists the names and dosages of Valsartan and Hydrochlorothiazide, two medications used to treat high blood pressure. The text also includes a measurement of DBP (diastolic blood pressure) taken before treatment.*

FDA Label Image

Valsartan Structural Formula (Image 05)

FDA Label Image

Hydrochlorothiazide Structural Formula (Image 06)

FDA Label Image

Label Image (Lbl500905985)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.